市場調查報告書
商品編碼
1535142
ICP 監測設備市場:依細分市場劃分的規模、佔有率、法規、償付、程序、到2033年的預測ICP Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
ICP 監測設備是用於測量患有導致腦內壓升高的神經系統疾病的患者的顱內壓(ICP)的醫療設備。這些神經系統疾病包括創傷性腦損傷、蜘蛛網膜下腔出血、腦積水和腦腫瘤。監測顱內壓很重要,因為顱內壓升高會導致腦損傷和其他嚴重併發症。
創傷性腦損傷(TBI)是使用 ICP 監測設備的主要原因。使用 EVD 進行 ICP 監測被認為是黃金標準,因為它允許腦脊髓液引流的額外治療功能。限制使用 EVD 進行 ICP 監測的因素之一是在心室尺寸較小或腦腫脹的患者中插入 EVD 很困難。此外,長期使用EVD進行ICP監測會增加顱內感染的風險。
本報告深入探討了全球 ICP 監測設備市場,包括競爭格局、SWOT 分析、到2033年的市場預測以及區域和國家趨勢。
ICP Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.
ICP monitoring devices are medical devices used to measure intracranial pressure (ICP) in patients with neurological conditions that can cause increased pressure in the brain. These neurological conditions may include traumatic brain injury, subarachnoid hemorrhage, hydrocephalus, and brain tumors. Monitoring ICP is important because increased pressure in the brain can lead to brain damage and other serious complications.
Traumatic brain injury (TBI) is the primary cause of ICP monitoring device usage. ICP monitoring using an EVD is considered as the gold standard as the technique allows an additional therapeutic function of CSF drainage. One factor which limits the use of EVDs for ICP monitoring is the difficulty of inserting the device in patients with small ventricle size or in patients with brain swelling. Also, long term use of EVDs for ICP monitoring increases the risk of intracranial infection.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed ICP Monitoring Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Integra LifeSciences Corp, Medtronic Plc, Natus Medical Inc, Spiegelberg GmbH & Co KG, Sophysa SA, Raumedic AG, Proteses Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -